73 Results for "

GPR40

" in MedChemExpress (MCE) Product Catalog:
Products (73)

73 Results for "GPR40" in MCE Product Catalog:

21
21 Publications Verification
Cat. No.: HY-50691
CAS No.: 306974-70-9
Research Areas:  

Metabolic Disease

GW-1100 is a selective GPR40 antagonist with a pIC50 of 6.9.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-10480
CAS No.: 1000413-72-8
Purity:  98.97%
Synonyms: TAK-875
Research Areas:  

Metabolic Disease

Fasiglifam (TAK-875) is a potent, selective and orally bioavailable GPR40 agonist with EC50 of 72 nM.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-15589
CAS No.: 885101-89-3
Purity:  99.23%
GW9508 is a potent and selective G protein-coupled receptors FFA1 (GPR40) and GPR120 agonist with pEC50s of 7.32 and 5.46, respectively. GW9508 shows ~100-fold selectivity for GPR40 over GPR120. GW9508 is inactive against other GPCRs, kinases, proteases, integrins and PPARs. GW9508 is a glucose-sensitive insulin secretagogue and an ATP-sensitive potassium (KATP) channels opener. Anti-inflammatory and anti-atherosclerotic activities .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-132265
CAS No.: 1656261-09-4
Purity:  99.88%
Research Areas:  

Metabolic Disease

SCO-267 is an allosteric GPR40 full agonist. SCO-267 can be used for the research of chronic diseases including diabetes .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101906
CAS No.: 346692-04-4
Purity:  99.57%
Research Areas:  

Metabolic Disease

DC260126 is a potent antagonist of GPR40 (FFAR1). DC260126 dose-dependently inhibits GPR40-mediated Ca 2+ elevations stimulated by linoleic acid, oleic acid, palmitoleic acid and lauric acid (IC50: 6.28, 5.96, 7.07, 4.58 μM, respectively) . DC260126 could protect MIN6 β cells from palmitate-induced ER stress and apoptosis .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15697
CAS No.: 1402601-82-4
Purity:  99.07%
Research Areas:  

Metabolic Disease

TUG-770 is a potent, selective and orally active GPR40/FFA1 agonist with an EC50 of 6 nM for human FFA1. TUG-770 shows a high selectivity for FFA1 over FFA2, FFA3, FFA4, PPARγ, other receptors, transporters, and enzymes. TUG-770 can be uesd for type 2 diabetes research . TUG-770 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-13467
CAS No.: 1142214-62-7
Purity:  99.65%
Research Areas:  

Metabolic Disease

AM-1638 is an orally active full agonist of GPR40 (EC50: 0.16 μM). AM-1638 increases the expression of antioxidant molecules (HO-1 and NQO-1). AM1638 blocks Palmitate (HY-N0830)-mediated superoxide production and ER stress. AM-1638 has antidiabetic activity and improves glycemic control in BDF mice with diet-induced obesity (DIO). AM-1638 demonstrates excellent oral bioavailability (mouse, >100%; rat, 72%; and cyno, 71%) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-13967B
CAS No.: 1259389-38-2
Purity:  99.00%
Research Areas:  

Metabolic Disease

AMG 837 calcium hydrate is an orally active, selective GPR40/FFA1 agonist with an EC50 of 1.5 nM against human GPR40. AMG 837 calcium hydrate stimulates insulin secretion in a glucose-dependent manner, and effectively improves glycemic control in both normal and diabetic rodent models . AMG 837 calcium hydrate binds to the BacA protein and impairs the survival and replication of Brucella. AMG 837 calcium hydrate can be used in research related to type 2 diabetes and brucellosis .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-13967
CAS No.: 865231-46-5
AMG 837 is an orally active, selective GPR40/FFA1 agonist with an EC50 of 1.5 nM against human GPR40. AMG 837 stimulates insulin secretion in a glucose-dependent manner, and effectively improves glycemic control in both normal and diabetic rodent models . AMG 837 binds to the BacA protein and impairs the survival and replication of Brucella. AMG 837 can be used in research related to type 2 diabetes and brucellosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1021
CAS No.: 1617-90-9
Vincamine is a monoterpenoid indole alkaloid extracted from the Madagascar periwinkle. Vincamine is a peripheral vasodilator and exerts a selective vasoregulator action on the brain microcapilar circulation . Vincamine is GPR40 agonist and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS). Vincamine improves glucose homeostasis in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19835
CAS No.: 1423018-12-5
Research Areas:  

Metabolic Disease

LY2922470 is a selective and orally active agonist for the G protein-coupled receptor 40 (GPR40). LY2922470 activates GPR40-mediated β-arrestin recruitment with EC50s of 7 nM (human GPR40), 1 nM (mouse GPR40) and 3 nM (rat GPR40). LY2922470 can be used for research of type 2 diabetes mellitus (T2DM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100775
CAS No.: 1254472-97-3
Purity:  99.78%
Synonyms: Setogepram sodium; PBI-4050 sodium
Fezagepras (Setogepram) sodium acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84 . Fezagepras sodium decreases renal, liver and pancreatic fibrosis . Fezagepras sodium exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100775A
CAS No.: 1002101-19-0
Purity:  99.38%
Synonyms: Setogepram; PBI-4050
Fezagepras (Setogepram) acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84 . Fezagepras decreases renal, liver and pancreatic fibrosis . Fezagepras exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions .
loading...
    loading...
Cat. No.: HY-103083
CAS No.: 2102196-57-4
Purity:  98.38%
Research Areas:  

Metabolic Disease

GPR40 agonist 4 is a potent free fatty acid receptor 1 (FFA1/ GPR40) agonist with a pEC50 of 7.54.
loading...
    loading...
Cat. No.: HY-123297
CAS No.: 1236109-67-3
Purity:  99.90%
Research Areas:  

Metabolic Disease

TUG-469 is a selective free fatty acid receptor 1 (FFA1/GPR40) agonist with an EC50 value of 19 nM. TUG-469 is >200-fold selective for FFA1 over FFA4. TUG-469 significantly improves glucose tolerance in pre-diabetic mice. TUG-469 can be used for the research of diabetes .
loading...
    loading...
Cat. No.: HY-147351
CAS No.: 1798751-25-3
Purity:  99.64%
Research Areas:  

Metabolic Disease

GPR40 agonist 6 (Compound 7a) is a potent and selective free fatty acid receptor 1 (FFAR1 or GPR40) agonist with an EC50 of 0.058 μM .
loading...
    loading...
Cat. No.: HY-124571
CAS No.: 376616-73-8
Purity:  99.88%
Target:  

GPR84

Research Areas:  

Inflammation/Immunology

ZQ-16 is a potent and selective GPR84 agonist with an EC50 value of 0.213 μM. ZQ-16 has no activity on the other free fatty acid receptors (FFARs), including GPR40, GPR41, GPR119 and GPR120 .
loading...
    loading...
Cat. No.: HY-148418
CAS No.: 1206629-08-4
Purity:  99.78%
Research Areas:  

Metabolic Disease

TUG-499 is a selective free fatty acid receptor 1 (FFAR1 or GPR40) (Free Fatty Acid Receptor) agonist with a pEC50 of 7.39. TUG-499 exhibits >100-fold selectivity over the related receptors FFA2, FFA3, and the nuclear receptor PPARγ and other diverse receptors, ion channels, and transporters. TUG-499 can be used for the research of type 2 diabetes . TUG-499 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-16619
CAS No.: 1222088-90-5
Research Areas:  

Metabolic Disease

AM-5262 is a GPR40 full agonist with an EC50 value of 0.081 μM. AM-5262 can be used for the research of type II diabetes .
loading...
    loading...
Cat. No.: HY-111763
CAS No.: 874755-26-7
Purity:  98.28%
Research Areas:  

Metabolic Disease

GPR40/FFAR1 modulator 1 is an agonist and an allosteric modulator for Gq-coupled free fatty acid receptor 1 (GPR40/FFAR1) .
loading...
    loading...